Intravascular Large B-Cell Lymphoma (IVLBCL) is a rare and often aggressive form of non-Hodgkin lymphoma in which malignant B cells proliferate predominantly within the lumina of small blood vessels.
News-Medical.Net on MSN
Most T-cell/histocyte-rich large B-cell lymphoma patients can safely receive a less toxic treatment
Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive a less toxic treatment than the ...
We retrospectively analyzed 106 patients (59 men, 47 women) with IVLBCL who received chemotherapy either with rituximab (R-chemotherapy, n = 49) or without rituximab (chemotherapy, n = 57) between ...
View all available purchase options and get full access to this article.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback